2019 Immuno-Oncology: A Future Look This intimate, invitation-only event for media and health care investment analysts is hosted by Cancer Research Institute at the New York Academy of Sciences. It features both a panel of leading academic scientific experts in immunotherapy, including 2018 Nobel Prize winner and Director of CRI’s Scientific Advisory Council, Dr. James P. Allison, and a fireside chat with chief science officers representing pharma and biotech leaders to share their points of view on what’s next in the IO field. Watch a Recording of Immuno-Oncology: A Future Look Read a Recap of Immuno-Oncology: A Future Look When Friday, June 21, 2019 Registration: 9am Panel Sessions: 10am-12pm Lunch Reception: 12pm Where The New York Academy of Sciences 7 World Trade Center 250 Greenwich Street, Floor 40 New York, NY 10007 Academic Panel James P. Allison, PhD, 2018 Nobel Laureate Chair, Department of Immunology, University of Texas MD Anderson Cancer Center Philip D. Greenberg, MD Head of Immunology, Fred Hutchinson Cancer Research Center Robert H. Vonderheide, MD, DPhil Director, Abramson Cancer Center, University of Pennsylvania Jill O'Donnell-Tormey, PhD (Moderator) CEO and Director of Scientific Affairs, Cancer Research Institute Industry Fireside Chat Awny Farajallah, MD, FACP Vice President, Head U.S. Medical, Bristol-Myers Squibb George D. Yancopoulos, MD, PhD Founder, President, and Chief Scientific Officer, Regeneron Meg Tirrell (Moderator) Reporter, Biotechnology and Pharmaceuticals, CNBC Opening Remarks Andrew K. Tsai Co-Chairman, CRI Board of Trustees Co-Founder and Chief Investment Officer, Chalkstream Capital Group Read more: Post navigation Conversations About Cancer Immunotherapy: Speaking With Your Oncologist Read Story CRI 33rd Annual Awards Dinner Read Story
